Waiting now on the UCSF and the P2B Combo Merck Keytruda FDA Protocol details.
$ONCS Savvy DD Shareholders "Buy, Hold, Accumulate" on the cheap as the FDA finalizes details on the P2B Melanoma cancer Combo Trial. There are 70% persons with late stage Melanoma that will die and $ONCS Combo EP+IL12 offers the opportunity to increase the ORR saving many lives.
....@spicknspan...correct and massive Failure last week at the resistance zone 7.25-7.50 ....no support strength at 6.50 and now pray 6 dollar zone holds .